Jia Meng, Wang Zhidong
Department of Radiobiology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, China.
Front Cell Dev Biol. 2022 Mar 3;10:861451. doi: 10.3389/fcell.2022.861451. eCollection 2022.
Accidental radiation exposures such as industrial accidents and nuclear catastrophes pose a threat to human health, and the potential or substantial injury caused by ionizing radiation (IR) from medical treatment that cannot be ignored. Although the mechanisms of IR-induced damage to various organs have been gradually investigated, medical treatment of irradiated individuals is still based on clinical symptoms. Hence, minimally invasive biomarkers that can predict radiation damage are urgently needed for appropriate medical management after radiation exposure. In the field of radiation biomarker, finding molecular biomarkers to assess different levels of radiation damage is an important direction. In recent years, microRNAs have been widely reported as several diseases' biomarkers, such as cancer and cardiovascular diseases, and microRNAs are also of interest to the ionizing radiation field as radiation response molecules, thus researchers are turning attention to the potential of microRNAs as biomarkers in tumor radiation response and the radiation toxicity prediction of normal tissues. In this review, we summarize the distribution of microRNAs, the progress on research of microRNAs as markers of IR, and make a hypothesis about the origin and destination of microRNAs after IR.
工业事故和核灾难等意外辐射暴露对人类健康构成威胁,而医疗过程中电离辐射(IR)造成的潜在或实质性损伤也不容忽视。尽管IR对各个器官造成损伤的机制已逐渐得到研究,但对受辐射个体的治疗仍基于临床症状。因此,迫切需要能够预测辐射损伤的微创生物标志物,以便在辐射暴露后进行适当的医疗管理。在辐射生物标志物领域,寻找能够评估不同程度辐射损伤的分子生物标志物是一个重要方向。近年来,微小RNA作为癌症和心血管疾病等多种疾病的生物标志物已被广泛报道,并且微小RNA作为辐射反应分子在电离辐射领域也备受关注,因此研究人员开始关注微小RNA作为肿瘤辐射反应生物标志物以及正常组织辐射毒性预测指标的潜力。在本综述中,我们总结了微小RNA的分布情况、微小RNA作为IR标志物的研究进展,并对IR后微小RNA的来源和去向提出了假设。